Long-Sheng Lu Selected Research

Radiotherapy

8/2022	Retrospective Analysis for Dose Reduction to Organs at Risk with New Personalized Breast Holder (PERSBRA) in Left Breast IMRT.
1/2022	Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC).
9/2020	FOXD1 Repression Potentiates Radiation Effectiveness by Downregulating G3BP2 Expression and Promoting the Activation of TXNIP-Related Pathways in Oral Cancer.
12/2019	Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme.
9/2019	Nicotinic Acetylcholine Receptor Subunit Alpha-5 Promotes Radioresistance via Recruiting E2F Activity in Oral Squamous Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Long-Sheng Lu Research Topics

Disease

15	Neoplasms (Cancer) 12/2023 - 01/2018
4	Breast Neoplasms (Breast Cancer) 08/2022 - 03/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2021 - 11/2020
2	Mouth Neoplasms (Oral Cancer) 09/2020 - 02/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 12/2019
2	Atherosclerosis 01/2018 - 01/2013
2	Wounds and Injuries (Trauma) 06/2013 - 05/2007
2	Insulin Resistance 07/2008 - 08/2007
1	Sarcoma (Soft Tissue Sarcoma) 04/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022
1	Heart Diseases (Heart Disease) 08/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Necrosis 01/2022
1	Bacterial Infections (Bacterial Infection) 11/2021
1	Fuchs' Endothelial Dystrophy 09/2021
1	Myocardial Infarction 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Death (Near-Death Experience) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Circulating Neoplastic Cells 11/2020
1	Colonic Neoplasms (Colon Cancer) 03/2020
1	Leiomyosarcoma 01/2020
1	Brain Neoplasms (Brain Tumor) 12/2019
1	Squamous Cell Carcinoma of Head and Neck 09/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Gastric Outlet Obstruction 06/2013
1	Esophageal Stenosis (Esophageal Stricture) 06/2013
1	Pathologic Constriction (Stenosis) 06/2013
1	Acute Coronary Syndrome 01/2013
1	Heart Failure 11/2012
1	Cardiotoxicity 11/2012

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 11/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 03/2006
3	Therapeutic UsesIBA 01/2021 - 11/2020
3	CholesterolIBA 08/2007 - 05/2003
2	Carboplatin (JM8)FDA LinkGeneric 04/2023 - 01/2020
2	LipidsIBA 08/2022 - 01/2018
2	Histones (Histone)IBA 01/2020 - 12/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 12/2019
2	Glucose (Dextrose)FDA LinkGeneric 07/2008 - 08/2007
2	Insulin (Novolin)FDA Link 07/2008 - 08/2007
1	Etoposide (VP 16)FDA LinkGeneric 04/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2023
1	Vincristine (Oncovin)FDA LinkGeneric 04/2023
1	Ifosfamide FDA LinkGeneric 04/2023
1	Filgrastim (Neupogen)FDA Link 04/2023
1	ferric oxide (iron oxide)IBA 10/2022
1	polypyrroleIBA 10/2022
1	AfatinibIBA 10/2022
1	Tyrosine Kinase InhibitorsIBA 10/2022
1	Growth Factor ReceptorsIBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	Drug CarriersIBA 08/2022
1	CytokinesIBA 01/2022
1	PlatinumIBA 12/2021
1	MetalsIBA 11/2021
1	CollagenIBA 10/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	P-SelectinIBA 01/2021
1	DNA Polymerase thetaIBA 12/2020
1	Docetaxel (Taxotere)FDA Link 12/2020
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	SolutionsIBA 11/2020
1	LuciferasesIBA 09/2020
1	InterferonsIBA 09/2020
1	Biomarkers (Surrogate Marker)IBA 09/2020
1	AlginatesIBA 08/2020
1	HydrogelsIBA 08/2020
1	Sincalide FDA Link 03/2020
1	Thromboplastin (Tissue Factor)IBA 03/2020
1	Conditioned Culture MediaIBA 03/2020
1	Thrombin FDA Link 03/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2019
1	piperlongumineIBA 02/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Interleukin-12 (IL 12)IBA 01/2018
1	Free RadicalsIBA 01/2018
1	CausticsIBA 06/2013
1	Atorvastatin (Lipitor)FDA Link 01/2013
1	C-Reactive ProteinIBA 01/2013
1	Estrogen ReceptorsIBA 07/2008

Therapy/Procedure

5	Radiotherapy 08/2022 - 09/2019
4	Therapeutics 01/2023 - 01/2018
3	Drug Therapy (Chemotherapy) 04/2023 - 12/2019
1	Lasers (Laser) 11/2022
1	Photothermal Therapy 10/2022
1	Segmental Mastectomy (Lumpectomy) 08/2022
1	Ultrasonic Surgical Procedures 01/2022
1	Corneal Transplantation (Keratoplasty) 09/2021
1	Length of Stay 01/2021
1	Hospice Care (Care, Bereavement) 01/2021
1	Palliative Care (Palliative Therapy) 01/2021
1	Castration 12/2020
1	Chemoradiotherapy 01/2020
1	Immunotherapy 01/2018
1	Immunomodulation 01/2018
1	Catheters 06/2013